Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Feb 20 | 2020FDA Issues Final Rule on Definition of "biological product"; ATTD 2020 Key Press Releases (Feb 20)Purchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Feb 19 | 2020Insulet Partners with Dexcom and Abbott; ATTD 2020 Key Press Releases (Feb 19)Purchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Feb 19 | 2020Medtronic CY Q4 '19 (FY Q3 '20); Cigna Reimburses Eversense Implantable CGM; Diasome HDV-Lispro Ph2 Topline DataPurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA, SGLT2i Feb 14 | 2020AstraZeneca Q4 '19 Earnings UpdatePurchase Blast
$599
Posted in: Insulin Delivery Feb 13 | 2020Insulet Omnipod DASH Software Bug; No Injuries ReportedPurchase Blast
$599
Posted in: Insulin Delivery Feb 12 | 2020Medtronic Recalls 630G/670G Pumps After Thousands of Injuries and One DeathPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Feb 11 | 2020Senseonics Integrates with Companion Medical; Nemaura Medical CY Q4 '19 Earnings UpdatePurchase Blast
$599
Posted in: Insulin Delivery, Other Feb 10 | 2020Zealand to Acquire Valeritas; vTv Positive Ph2 Data for TTP399 in T1DMPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist Feb 06 | 2020Novo Q4 '19 London Earnings; Sanofi and BD Q4 '19 Earnings UpdatesPurchase Blast
$599
Posted in: Dual/triple agonist Feb 05 | 2020Tirzepatide CVOT Record Available on CT.govPurchase Blast
$599
Posted in: DPP-IVi, SGLT2i Feb 05 | 2020Merck Keeps Januvia As it Spins Off Other Legacy BrandsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucagon Feb 05 | 2020Positive Topline Novo QW Insulin Results; Novo Q4 '19 Earnings UpdatePurchase Blast
$599
Posted in: Glucose Monitoring, Other Feb 03 | 2020Dexcom Non-intensive G6 CGM Updated Approval; Dexcom G5 Receiver Recall; FDA Concludes MET NDMA Impurity InvestigationPurchase Blast
$599
Posted in: Bolus Insulin, GLP-1RA Jan 31 | 2020Rybelsus and URLi Receive Positive CHMP OpinionsPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, GLP-1RA + Basal, Glucagon, Glucose Monitoring, Insulin Delivery, Other, SGLT2i Jan 31 | 2020Thoughts on New CVS Program to Eliminate Diabetes Drug OOP CostsPurchase Blast
$599
Posted in: Basal Insulin, Dual/triple agonist, GLP-1RA, Insulin Delivery, SGLT2i Jan 30 | 2020Lilly and Roche Q4 '19 Earnings UpdatesPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Other Jan 28 | 2020Lilly to Donate Insulin Pens; Fractyl Launches Revita DMR in the UKPurchase Blast
$599
Posted in: DPP-IVi, SGLT2i Jan 28 | 2020Trijardy XR (empa/lina/met XR FDC) Approved; Trijardy Label and Market AnalysisPurchase Blast